Proteostasis Therapeutics Inc

Proteostasis Therapeutics Inc. is a clinical stage biopharmaceutical company based in Boston, Massachusetts. With seven employees, the company specializes in developing innovative treatments for serious diseases. The company generates approximately $50 million in annual revenue. Proteostasis Therapeutics focuses on developing small molecule therapeutics to address cystic fibrosis and other diseases stemming from impaired protein processing. Their research and development efforts center around identifying therapies that effectively restore protein function, offering potential solutions for patients battling these debilitating conditions. The company distinguishes itself through a dedicated research team and a targeted approach to drug development. Proteostasis Therapeutics prioritizes identifying therapies that address the underlying cause of disease, aiming to provide meaningful and lasting improvements in patient outcomes. For more details about Proteostasis Therapeutics Inc., visit their website at proteostasis.com or follow them on social media (@PTI_biotech).